CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong
· Delayed Price · Currency is HKD 15.39
+1.47 (10.56%)
Mar 10, 2026, 1:34 PM HKT
HKG:2171 Revenue
In the year 2025, CARsgen Therapeutics Holdings had annual revenue of 125.66M CNY with 218.74% growth. CARsgen Therapeutics Holdings had revenue of 50.96M in the half year ending June 30, 2025.
Revenue
125.66M CNY
Revenue Growth
+218.74%
P/S Ratio
55.33
Revenue / Employee
338.71K CNY
Employees
371
Market Cap
7.74B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ocumension Therapeutics | 595.79M |
| Laekna | 5.07M |
| Jacobio Pharmaceuticals Group | 220.66M |
| CK Life Sciences Int'l., (Holdings) | 5.49B |
| Alphamab Oncology | 861.24M |
| Viva Biotech Holdings | 2.01B |
| Lepu Biopharma | 767.54M |
| Abbisko Cayman | 681.17M |